PATENT CLAIM ANALYSIS

Application Number: 16157767
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "176000"]

Abstract:
In one aspect, the invention relates to methods for treating muscle atrophy by providing to an animal in need thereof an effective amount of a compound. The compound can modulate the expression levels of multiple mRNA of a muscle atrophy signature. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 10):
The method according to  claim 9 , wherein the compound is or a stereoisomer, tautomer, solvate, or pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 97.0
- Lexical Diversity: 1.44
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14124582', '15051246', '16003184', '14612636', '13698645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8012932876977332
- 35 USC 102 Novelty (BERT): 0.6122647737719521
- Combined Prediction Score: 0.7823904363051551
- Mean Citation Score: 542.6498740000002
- Max Citation Score: 670.6607700000002
- Similarity Product: 446.3052649413049

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test